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http://dx.doi.org/10.1016/j.stemcr.2017.04.003SUMMARYDuring development, hematopoietic stemcells (HSCs) emerge in the aorta-gonad-mesonephros (AGM) region through a process ofmulti-
step maturation and expansion.While proliferation of adult HSCs is implicated in the balance between self-renewal and differentiation,
very little is known about the proliferation status of nascent HSCs in the AGM region. Using Fucci reporter mice that enable in vivo visu-
alization of cell-cycle status, we detect increased proliferation during pre-HSC expansion followed by a slowing downof cycling once cells
start to acquire a definitive HSC state, similar to fetal liver HSCs. We observe time-specific changes in intra-aortic hematopoietic clusters
corresponding to HSC maturation stages. The proliferative architecture of the clusters is maintained in an orderly anatomical manner
with slowly cycling cells at the base and more actively proliferating cells at the more apical part of the cluster, which correlates with
c-KIT expression levels, thus providing an anatomical basis for the role of SCF in HSC maturation.INTRODUCTION
The AGM region plays an important role in development
of HSCs that give rise to the adult hematopoietic system
(Kumaravelu et al., 2002; Medvinsky and Dzierzak, 1996;
Mu¨ller et al., 1994; Medvinsky et al., 2011; Ciau-Uitz
et al., 2016). The pool of immature precursors (pre-HSCs),
which cannot yet repopulate adult irradiated recipients,
gradually expands and matures in the AGM region (Rybt-
sov et al., 2016). This concealed dramatic expansion of
pre-HSCs culminates in the emergence of a few definitive
(d)HSCs in the E11 AGM region followed by a sudden
increase in their number in the E12 fetal liver, detectable
by direct transplantation into adult irradiated recipients
(Kumaravelu et al., 2002; Ema and Nakauchi, 2000; Rybt-
sov et al., 2016).
Cell proliferation is one of critical factors involved in
many developmental processes (Budirahardja and Go¨nczy,
2009; Lange and Calegari, 2010; Kaldis and Richardson,
2012), and theproliferative status of adultHSCs is an impor-
tant feature of their biology. In the fetal liver, HSCs expand,
probably through symmetric division until week 3–4 post-
natally, thenbecomequiescent (Bowie et al., 2006). Prolifer-
ative quiescence in the adultmaintains ‘‘stemness’’ of HSCs
andprevents their exhaustion (Passegue´ et al., 2005;Wilson
et al., 2008; Seita andWeissman,2010;Takizawaet al., 2011;
Pietras et al., 2011; Nakamura-Ishizu et al., 2014). Physio-
logical demands drive HSCs to enter proliferation, while a
balance is maintained to ensure HSC self-renewal and dif-
ferentiation. The bonemarrownichemaintains HSC quies-This is an open access articence throughessential signaling (Jude et al., 2008;Mendel-
son and Frenette, 2014; Morrison and Scadden, 2014). By
contrast, downstream committed progenitors, which are
involved in the immediate production of mature blood
cells, are significantly more proliferative (Passegue´ et al.,
2005).
Given the importance of proliferation in cell commit-
ment and differentiation, here we have studied prolifera-
tive changes during HSC maturation steps, which to date
have not been studied in detail. We showed previously
that in culture developing HSCs of the AGM region prolif-
erate slower than committed progenitors (Taoudi et al.,
2008). More recent in vivo analysis of the dramatic pre-
HSC expansion in the AGM region suggests that prolifera-
tion or/and cell recruitment may play a role (Rybtsov et al.,
2016).
In vitro modeling has proved to be a powerful and infor-
mative approach for the identification of pre-HSC states
and dissection of HSC developmental mechanisms (Taoudi
et al., 2008). HSCs develop through a multi-step process:
pro-HSC/ pre-HSC I/ pre-HSC II/ dHSC, which in-
volves sequential upregulation of hematopoietic markers
CD41 (Itga2b), RUNX1 (AML1), CD43 (Spn), and CD45
(Ptprc) in VE-CADHERIN+ (VC) precursors (Rybtsov et al.,
2011, 2014; Taoudi et al., 2008; Medvinsky and Dzierzak,
1996; Liakhovitskaia et al., 2014; Swiers et al., 2013;
Yoder et al., 1997). Pro-HSCs (VC+CD41loCD43CD45)
emerge at embryonic day 9.5 (E9.5), pre-HSCs type I
(VC+CD41loCD43+CD45) at E10.5, and pre-HSCs type II
(VC+CD41loCD43+CD45+) at E11.5 stages. Low dHSCStem Cell Reports j Vol. 8 j 1–14 j June 6, 2017 j ª 2017 The Authors. 1
cle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. Changes in Proliferative Status of Developing HSCs
(A) Representation of cell-cycle analysis by Fucci reporters.
(B) Experimental design of transplantation assays of pro-/pre-HSCs and dHSCs.
(C) Flow-cytometry analysis of HSC precursors and committed progenitors in Fucci embryos at different developmental stages (three
independent experiments) shown by bar graphs (error bars show SEM) and representative dot plots. All the populations analyzed are gated
(legend continued on next page)
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similar to pre-HSCs type II, they can be detected by direct
transplantations into irradiated recipients. Pro-/pre-HSCs
have been identified in hematopoietic clusters budding
from the endothelium of major embryonic arteries (Rybt-
sov et al., 2011, 2014; Taoudi et al., 2008; Yokomizo and
Dzierzak, 2010; Kissa and Herbomel, 2010; Boisset et al.,
2011; Gordon-Keylock et al., 2013; Ciau-Uitz et al., 2016).
Functional assessment of cell proliferation in live cells
often involves Hoechst staining, which can be toxic and
can alter the experimental outcome (Parish, 1999). Instead,
we used the fluorescent ubiquitination-based reporter
(Fucci) system, which enables noninvasive in vivo visu-
alization of the cell-cycle status and their isolation for
functional analysis (Sakaue-Sawano et al., 2008; Yo et al.,
2015; Zielke and Edgar, 2015).
We describe here that pro-HSCs (at E9.5) initially slowly
cycle, then enter active proliferation during E10.5–E11.5,
which correlates with the expansion of the pro-/pre-HSC
pool (Rybtsov et al., 2016). However, this phase is followed
by gradual slowing down of proliferation, the first signs
of which can be already observed in AGM dHSCs, in keep-
ing with gradual acquisition of adult status by dHSCs.
We also describe the orderly architectural evolvement of
intra-aortic clusters in which stepwise HSC maturation
and proliferation are linked. It is suggested that the prolif-
erative pattern within the cluster is defined by c-KIT/SCF
signaling.RESULTS
Changes in Proliferative Status of Developing HSCs
To analyze the proliferative status of developing HSCs, we
used the Fucci dual reporter mouse lines (see Experimental
Procedures) appropriate for analysis of the hematopoietic
system (Yo et al., 2015; Zielke and Edgar, 2015). Two anti-
phase oscillating proteins that mark cell-cycle transitions
Cdt1 (genetically labeled by mKO2; red fluorescence) and
Geminin (genetically labeled bymAG; green fluorescence),
which are controlled by the cell-cycle machinery through
proteasomal degradation, have been used here as reporters.
Cdt1-mKO2 is expressed during G0 and G1 phases and theon Live Ter119 cells. The pro-HSC population is identified as VC+CD45
pre-HSC type I population is identified as VC+CD45CD41loCD43+, while
is identified as VC+CD45+CD41loCD43+ and the E11.5 progenitors as VC
(D) Transplantation assays of pro-/pre-HSCs and dHSCs after sorting on
experiments). *p < 0.05, **p < 0.01, ****p < 0.0001.
(E) Transplantation assays of fetal liver (LSK CD48) HSCs and bone ma
reporters (2–3 independent experiments). The dashed line shows the
**p = 0.005, ***p = 0.0006, ****p < 0.0001.
See also Figure S1 and Table S1.cells fluoresce red, while Geminin-mAG (Gem-mAG)marks
green the cells that are in S/G2/M phases (Figures 1A and
S1A). During the G1/S transition cells become yellow and
no reporter is expressed in early G1 phase (shown as gray)
(Figures 1A and S1A). Therefore, slowly cycling populations
are represented mainly by red (Cdt1-mKO2+) cells and
actively cycling populations are mainly green (Gem-
mAG+) cells.
Flow-cytometry analysis of Fucci reporter embryos
showed that in the caudal part of the E9.5 embryo endothe-
lial cells were mainly within S/G2/M and early G1 phases,
indicating that they were actively proliferative. Only
6.6% (±1.6%) of the endothelial population (VC+CD45
CD41CD43) were found in the G0/G1 phases of the cell
cycle (versus 54.8% ± 11.9% in S/G2/M, p = 0.0002) (Fig-
ure S1B). By contrast, a significant proportion of cells in
the pro-HSC population (VC+CD45CD41loCD43) were
in G0/G1 phases (23.7% ± 7.6% versus G0/G1 endothelial
population, p = 0.004), suggesting that a fraction of these
cells emerging from the endothelium slow down their
cycling (Figure 1C). Compared with the pro-HSC pop-
ulation, more committed hematopoietic progenitors
(VCCD45CD41loCD43+) (Rybtsov et al., 2014) were
actively proliferating (progenitors, 8.6% ± 9.3% versus
pro-HSC, 23.7% ± 7.6% in G0/G1; p = 0.02) (Figure 1C). To
functionally define the cell-cycle status of pro-HSCs, we
sorted Gem-mAG+ and Gem-mAG fractions of this popu-
lation, co-aggregated them with OP9 cells for 7 days in cul-
ture, and transplanted them into irradiated recipients, as
described previously (Rybtsov et al., 2014) (Figure 1B).
Only the Gem-mAG fraction generated transplantable
dHSCs, suggesting that pro-HSCs are slowly cycling (Fig-
ure 1D and Table S1). Meanwhile, both Gem-mAG+ and
Gem-mAG fractions of the pro-HSC population were
able togenerate colonies ofmyeloid cells inmethylcellulose
CFU-C assays (Figure S1C).
While the E9.5 endothelium is mainly proliferating, this
population slows down its cycle during the following days
of development since the proportion of G0/G1 endothelial
cells increases to 47% (±6.1) by E11.5 (versus E9.5: 6.6% ±
1.6%, p < 0.0001) (Figure S1B). In contrast to pro-HSCs
observed in E9.5–10.5 embryos, the proportion of E10.5
pre-HSC type I (VC+CD45CD41loCD43+) in the G0/G1CD41loCD43, while the progenitors are VC+CD45CD41loCD43+. The
the E10.5 progenitors are VC+CD45+. The pre-HSC type II population
CD45+. *p < 0.05, **p < 0.01, ***p < 0.005.
the basis of the Geminin-mAG reporter (at least three independent
rrow (LSK CD150+CD48) HSCs after sorting on the basis of the Fucci
5% chimerism threshold and the error bars show SEM. *p = 0.02,
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19.2% ± 4%, p = 0.03), suggesting that by this stage
the HSC lineage becomes more proliferative (Figure 1C).
Indeed, functional validation using ex vivo maturation
and transplantation showed that in contrast to E9.5 pro-
HSCs, pre-HSC type I resided in both the Gem-mAG+ and
Gem-mAG fraction, which is in line with the dramatic
expansion of the pre-HSC pool at E10.5 (Figure 1D and
Table S1) (Rybtsov et al., 2016).We observed higher repopu-
lation levels from the Gem-mAG+ fraction but no bias in
multi-lineage differentiation compared with the Gem-
mAG fraction (data not shown). Similar to the E9.5
pro-HSCpopulation,bothGem-mAG+andGem-mAG frac-
tions of E10.5 pre-HSC type I were equally capable of gener-
ating myeloid colonies in the methylcellulose (Figure S1C).
ByE11.5, immunophenotypic analysis showedadramatic
increase of G0/G1 cells in the pre-HSC type I population
compared with E10.5, from 8.5% ± 6.7% to 51.3% ± 10.3%
(p = 0.02), respectively (Figure 1C). By contrast, the more
advanced pre-HSC type II population (VC+CD45+CD41lo
CD43+Sca1+) was found mainly in early G1 and S/G2/M
phases associated with active cell cycling (19.3% ± 12.8%
and 50.7% ± 3.7%, respectively versus G0/G1: 19.7% ±
7.9%, p = 0.02) (Figure 1C). Previous analysis showed that
pre-HSCs emerge predominantly in the ventral domain of
the dorsal aorta (AoV)with some contribution from the dor-
sal domain (AoD) (Souilhol et al., 2016; Taoudi andMedvin-
sky, 2007). Interestingly, immunophenotypic analysis at
E11.5 revealed a larger proportion of the pre-HSC type I
population in S/G2/M phases from the AoD compared
with AoV (30% ± 7.1% versus 16.1% ± 8.7%, respectively;
p = 0.02), which is reminiscent of committed progenitor
cells (Figure S1B). By contrast, no proliferative difference
was observed between AoV- and AoD-derived endothelial
or pre-HSC type II populations (data not shown).
A striking change in cell-cycle status was observed in pre-
HSC type I by E11.5. Functional transplantations demon-
strated that in contrast to E10.5, these cells resided almost
exclusively inG0/G1, with only a few low repopulating cells
residing in S/G2/M phases (Figures 1D and S1D; Table S1).
By contrast, pre-HSCs type II were found in both Gem-
mAG+ and Gem-mAG fractions (Figure 1D). Notably,
direct transplantations (without prior culturing) showed
that mature E11.5 dHSCs were in G0/G1 phases, indicating
that acquisition of the adult status is accompanied
by reducing cycling (Figure 1D and Table S1). Although
both E11.5 pre-HSCs and dHSCs were predominantly
Gem-mAG, CFU-C were equally well represented by
both Gem-mAG+ and Gem-mAG fractions (Figure S1C).
When we analyzed E14.5 fetal liver, we found that
the majority of HSCs were also within G0/G1 or early
G1 phases (G0/G1: 44.8% ± 6.7%) and became quiescent
in the adult bone marrow (G0/G1: 93.1% ± 1.4%) (Fig-4 Stem Cell Reports j Vol. 8 j 1–14 j June 6, 2017ure S1B), in contrast to restricted progenitors (G0/G1
10.2% ± 0.8% in FL, p = 0.0005; G0/G1 69.2.8% ± 2.6% in
BM, p = 0.0002) (Figure S1B). These findings in com-
bination with transplantation assays (Figure 1E and
Table S1) are in line with previous reports (Bowie et al.,
2006, 2007a; Passegue´ et al., 2005). Based on limiting dilu-
tion transplantation analysis (Figure 1E) (ELDA; Hu and
Smyth, 2009), the numbers of fetal liver HSCs in G0/G1
phase were 17/100 cells and in S/G2/M phases were
0.3/100 cells.
Proliferative Structure of Intra-aortic Hematopoietic
Clusters
HSCs andmore committed progenitors develop in hemato-
poietic clusters that are budding from the endothelium of
major arteries during E10.5 (Garcia-Porrero et al., 1995;
North et al., 1999; Yokomizo and Dzierzak, 2010; Rybtsov
et al., 2011; Boisset et al., 2015). Fucci mice allowed us to
visualize the cell-cycle status within intra-aortic clusters.
In the E9.5 embryo (caudal part), hematopoiesis occurs in
two locations: pro-HSCs (CD41+CD43) develop in the
dorsal aorta and committed progenitors (CD41+CD43+)
form a string of large cell clusters in the omphalomesen-
teric artery (OMA) (Zovein et al., 2010; Rybtsov et al.,
2014). Hematopoietic cells are marked in these locations
by the transcription factor Runx1, including flat cells inte-
grated in the endothelial lining of the dorsal aorta (Figures
2A and 2A0) (Swiers et al., 2013; Rybtsov et al., 2014). We
sought to identify candidate pro-HSCs using the Fucci re-
porters. We found a few VC+RUNX1+ cells, closely associ-
ated with the endothelium of the dorsal aorta, which are
labeled by CD41 but not CD43 (Figures 2A, 2A0, S2A, and
S2A0) and which were also Cdt1-mKO2+ (Geminin-
mAG) (Figures 2B and 2B0), characteristic of pro-HSCs
identified by functional analysis (Figure 1D). It is conceiv-
able that true low-expressing CD41+ pro-HSCs were not
detectable using this immunofluorescence analysis. Our
previous study showed that committed progenitors local-
ized in the OMA are labeled by CD43 (Rybtsov et al.,
2014). Indicative of their active proliferation, the majority
of OMA CD43+ cells were Geminin-mAG+ (Cdt1-mKO2)
both by flow cytometry (Figure 1C) and confocal analysis
(Figures 2C, 2C0, S2B, and S2B0).
It is reasonable to assume that intra-aortic cell clusters are
formed through budding from the endothelium of the dor-
sal aorta andmay gradually build up through proliferation.
Confocal analysis showed that the base of E10.5 clusters
was VC+CD41+RUNX1+ (and also c-KIT+) but not CD43+,
and therefore harbored the most immature pro-HSC popu-
lation (Figures 3B, 3B0, and S3). Notably, these cells closely
associated with endothelium were in G0/G1 phases (Gemi-
nin-mAG/Cdt1-mKO2+) (Figures 3A, 3B, and 3B0) as E9.5
pro-HSCs (Figure 1D). These G0/G1 cells at the base were
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Figure 2. Localization and Cell-Cycle Status of CD41+Runx1+ Cells in the E9.5 Embryo
(A and A0) Wild-type E9.5 embryos stained against Runx1 and CD41. Low-magnification image (A) shows the Ao and OMA, while high
magnification (A0) shows the localization of VC+CD41+Runx1+ single cell in the dorsal aorta (white arrowhead) (at least three embryos).
(B) Geminin-mAG and (B0) Cdt1-mKO2 embryos stained against CD41 showing that pro-HSC phenotype cells (white arrowheads) in the
dorsal aorta are in G0/G1 (at least three embryos).
(C) Geminin-mAG and (C0) Cdt1-mKO2 embryos stained against CD43 showing that progenitors (VC+CD43+) are specifically localized in OMA
and they are Geminin-mAG+Cdt1-mKO2 (at least three embryos). Dashed line shows the endothelium of the OMA.
Ao, dorsal aorta; OMA, omphalomesenteric artery; A, D, P, V, anterior, distal, posterior, ventral, respectively. Scale bars: (A) 40 mm; (A0, B,
B0, C, C0) 10 mm. See also Figure S2.
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Table 1. Proliferative Structure of Intra-aortic Hematopoietic
Clusters
Sample
No. of
Clusters with
VC+CD45Cdt1+
Base
Total No. of
Clusters
% Clusters
with Cdt1+
Base
E10.5 Embryo 1 12 12 100
Embryo 2 14 19 74
Embryo 3 21 24 87
Embryo 4 6 9 67
E11.5 Embryo 1 4 5 80
Embryo 2 12 15 80
Embryo 3 6 15 40
Embryo 4 12 14 89
Embryo 5 3 5 60
Intra-aortic clusters counted in E10.5 and E11.5 Cdt1-mKO2 embryos
stained against CD45 and VC. The total number of clusters as well as the
number/percentage of clusters with slowly cycling VC+CD45Cdt1+ base
counted is shown.
Please cite this article in press as: Batsivari et al., Understanding Hematopoietic Stem Cell Development through Functional Correlation of
Their Proliferative Status with the..., Stem Cell Reports (2017), http://dx.doi.org/10.1016/j.stemcr.2017.04.003observed in67%–100%of clusters in four analyzed embryos
(Table 1). Meanwhile, more apically located cells, presum-
ably derived from the basal cells, were in S/G2/M phases
(Geminin-mAG+/Cdt1-mKO2). Among these actively
proliferating more apical cells were the VC+CD43+CD45
pre-HSC type I population and the committed VC+CD43+
CD45+ progenitor population (note that pre-HSC type II
are rare at this stage; Figures 3B, 3B0, S2C, andS2C0) (Rybtsov
et al., 2011, 2014). Similar polarized basal-apical orga-
nization was observed in the usually significantly larger
hematopoietic clusters of extra-embryonic (vitelline and
umbilical) arteries (Figures S4A–S4B0).
By the next day (E11.5), when HSC precursors have
matured further, we analyzed phenotypic changes in
intra-aortic clusters. The base of E11.5 intra-aortic clusters
was again represented by cells mainly in G0/G1 phases
(Geminin-mAG/Cdt1-mKO2+), which by this time upre-
gulated CD43 and acquired a pre-HSC type I phenotype
(CD45) (Figures 3C and 3C0), as observed in 40%–80%
of clusters in individual embryos (n = 5) (Table 1). More
apically located cells upregulated CD45+ and thus acquired
pre-HSC type II phenotype and, as expected from func-
tional transplantation studies, were both Geminin-mAG+
and Geminin-mAG (Figures 3C and 3C0).(B and C) Geminin-mAG and (B0, C0) Cdt1-mKO2 embryos stained for CD
HSCs (at least three embryos).
(D) Wild-type embryos stained against Ki67 (three embryos). White a
Scale bars: (A) 25 mm; (B, B0, C, C0, D) 10 mm. See also Table 1 and FAlthough Fucci analysis allowed us to visualize key
phases of the cell cycle in the developing HSC lineage,
this does not explain whether the cells are resting or
cycling. To address this issue, we used antibody staining
for Ki67 and found that all cells in the cluster, including
thosewhich are at its base (Cdt1+), were cycling (Figure 3D).
Thus, Fucci analysis here reveals differences not between
quiescent and cycling, but between slowly and rapidly
cycling cells within the developing HSC lineage in the
AGM region.c-KIT Expression Correlates with Cell-Cycle Status in
HSC Precursors
The c-KIT/SCF signaling pathway is critically important for
HSC development in the AGM region and in adult HSC
niches (Rybtsov et al., 2014; Ding et al., 2012). Asymmetric,
ventrally polarized expression of SCF in the AGM region
correlates with predominant formation of intra-aortic clus-
ters in the floor of the dorsal aorta (Souilhol et al., 2016).
Our analysis of E10.5 clusters showed that c-KITlow cells
in both intra-aortic and umbilical arteries were in G0/G1
phases, suggesting that they are slowly cycling (Figures
4A, 4A0, S4C, and S4C0, white arrows). Although we
observed c-KITlow slowly proliferating cells in various posi-
tions, these were mostly localized to the base of the cluster,
closely associated with endothelium (Figures 4A and
4A0). By contrast, high c-KIT levels correlated with actively
proliferating Geminin-mAG+ cells localized mainly
apically in the cluster (Figures 4A, 4A0, S4C, and S4C0, white
arrowheads). Accordingly, slowly cycling pre-HSCs type I
(as shown functionally, Figure 1D, E11.5) were enriched
for c-KITlow cells (G0/G1: 53.2% ± 7.4% are c-KIT
lo versus
5.3% ± 1.7% are c-KIThi, p = 0.0006) compared with more
actively cycling pre-HSC type II (G0/G1: 48.1% ± 3.3% are
c-KITlo versus 51.3% ± 3.2% are c-KIThi, p = not significant;
S/G2/M: 19.9% ± 2.6% are c-KIT
lo versus 65.9% ± 4.9% are
c-KIThi, p < 0.0001) (Figures 4B and Table S2), indicating
that one of the roles of c-Kit/SCF signaling might be in
expansion of the developing HSC pool (Rybtsov et al.,
2016) through regulation of their proliferation (Bowie
et al., 2007b; Sasaki et al., 2010; Shin et al., 2014).DISCUSSION
Cell proliferation plays an important role in various devel-
opmental processes. It underlies growth of tissues and or-
gans and is involved in cell-fate decisions (Fuchs, 2009;43 (B, B0) at E10.5 and CD45 (C and C0) at E11.5 to identify pro-/pre-
rrowheads show the cells at the base of the cluster.
igures S2–S4.
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Figure 4. c-KIT Expression Correlates with Cell-Cycle Status in HSC Precursors
(A) Localization and Intensity of c-KIT Expression in Intra-aortic Hematopoietic Clusters at E10.5 (A) Geminin-mAG and (A0) Cdt1-mKO2
embryos. White arrowheads show c-KIThi and Geminin-mAG+ (or in A0, Cdt1-mKO2), while white arrows show c-KITlo and Cdt1-mKO2+ (or
in A, Geminin-mAG) (at least three embryos).
(B) Representative dot plots of flow cytometry analysis of E11.5 AGM pre-HSCs and correlation of c-KIT expression level with cell-cycle
status (three independent experiments).
Scale bar, 10 mm. See also Figures S3 and S4; Table S2.
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mechanism enabling self-renewal and differentiation of
HSCs in the adult (Bowie et al., 2006; Pietras et al., 2011).
Here we used Fucci reporter mice to define the proliferative
status of the developing HSCs. Our conclusions based on
the ratio of Geminin-mAG+ and Cdt1-mKO2+ cells are
consistent with previously described proliferation rates of
fetal liver and bone marrow HSCs (Bowie et al., 2006,
2007a; Nygren et al., 2006, 2007b; Takizawa et al., 2011;
Fuchs, 2009).
During maturation, the developing HSC pool undergoes
massive expansionwithin the AGM region before coloniza-
tion of the fetal liver (Rybtsov et al., 2016). HSCmaturation8 Stem Cell Reports j Vol. 8 j 1–14 j June 6, 2017occurs through sequential upregulation of hematopoietic
markers (CD41, CD43, and CD45) (Taoudi et al., 2008;
Rybtsov et al., 2014). Fucci mice enabled visualization
and isolation of cells in G0/G1 (red) and S/G2/M (green)
phases, so that developing HSCs could be studied at both
the phenotypic and functional levels (Figure 5A).We found
that the Geminin-mAG but not Geminin-mAG+ frac-
tion of the E9.5 pro-HSC population was able to mature
into dHSCs, which could reconstitute adult irradiated
recipients, indicating that pro-HSCs are not cycling or
slowly cycling. By the next day (E10.5), upregulation
of CD43 marks the emergence of pre-HSCs type I, which
are actively proliferating since both Geminin-mAG+ and
P P P
II
I
I
I I
I
II II
dHSC
I I
B
E9.5 E10.5 E11.5
E9.5 E10.5 E11.5 E14.5 Adult
B
A
P I
A
I
II
dHSC FL HSC BM HSC
HE
Figure 5. Model: Changes and Heteroge-
neity in Proliferative Status of the Devel-
oping HSC Lineage and Their Organiza-
tion within the Intra-aortic Clusters
(A) Analysis of Fucci reporter mice defined
changes in the proliferative status of the
HSC precursors during development. The
dramatic expansion of the pre-HSC pool
during E10.5 correlates with their active
proliferation. There might be two scenarios
to explain the appearance of slowly cycling
pre-HSC type I in E11.5 AGM region; in
scenario A a fraction of proliferative E10.5
pre-HSCs type I slows down their cycling
and persists as type I until E11.5; in sce-
nario B this is a retarded E9.5 pro-HSC
fraction which matured into pre-HSC type I
while maintaining slow cycling. Also, dHSCs
are slowly cycling like their fetal liver
counterparts, while the adult bone marrow
HSCs are quiescent.
(B) Slowly cycling cells are frequently found
at the base of intra-aortic clusters, while
more rapidly cycling cells are located at more apical positions. The proliferative organization of intra-aortic clusters is maintained during
development of HSCs in the AGM region and is linked with their maturation. FL, fetal liver; BM, bone marrow; P, pro-HSC; I, pre-HSC
type I; II, pre-HSC type II.
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eration likely underlies the previously described dramatic
expansion of the pre-HSC pool (from 5 cells at early E10
to 50 cells by late E10.5) (Rybtsov et al., 2016). At E11.5
pre-HSCs type II mature and continue to proliferate, with
some bias toward the Geminin-mAG fraction, indicating
a slowing down in this process, which becomes apparent
in dHSCs. This slowing down of the cell cycle continues
further in fetal liver HSCs and, finally, in mainly quiescent
bone marrow HSCs (Figure 5A) (Bowie et al., 2007a; Yo
et al., 2015).
This study confirms our previous observations that
certain states in HSC development can persist for longer
than one developmental day (Rybtsov et al., 2016). How-
ever, while the proliferative status of E9.5 and E10.5 pro-
HSCs is similar, pre-HSCs type I at E11.5 differ from E10.5
by their slow cycling. The origin of the slowly cycling
E11.5 pre-HSC type I population is not clear. One possible
scenario (Figure 5A, scenario A) is that a fraction of prolifer-
ative E10.5 pre-HSCs type I slows down their cycling and
persists as type I until E11.5. Another scenario (Figure 5A,
scenario B) is that a fraction of retarded E9.5 pro-HSCs
matured into pre-HSC type I while maintaining their slow
cycling. Whether these distinct pre-HSC fractions can
contribute to the heterogeneity of the adult HSC pool (Sie-
burg et al., 2010; Dykstra et al., 2007; Benz et al., 2012; Ema
et al., 2014) needs further investigation. TheG0/G1 status of
E11.5 pre-HSC type I observed here contradicts a recentstudy reporting that these cells are predominantly in
S/G2/M phases, which could be explained by their short-
termmonitoring of recipients that revealed committed pro-
genitors rather than HSCs (Zhou et al., 2016).
The emergence of HSCs in the AGM region is manifested
morphologically by the formation of intra-aortic hemato-
poietic clusters (Rybtsov et al., 2011, 2014; Taoudi et al.,
2008; Yokomizo and Dzierzak, 2010; Kissa and Herbomel,
2010; Boisset et al., 2011). Although this process has not
been investigated in detail experimentally, it could be
assumed that endothelial-derived HSC precursors prolifer-
ate and mature to form the cluster. Our current functional
analysis using Fucci mice allowed us to better define the
identity of developing HSCs and dynamically map their
location within intra-aortic clusters in a stage-specific
manner. The day before clusters are formed, at E9.5, single
slowly cycling cells of the VC+RUNX1+CD41+ phenotype
were found attached to the aortic endothelium. However,
since levels of CD41 expression detected under the micro-
scope and by flow cytometry cannot be directly correlated,
given the presence of few pro-HSCs per embryo (Rybtsov
et al., 2016), this raises the possibility that true, CD41low
pro-HSCs escaped our analysis. By the next daywhen active
formation of intra-aortic clusters occurs, slowly cycling
(G0/G1) pro-HSCs remain associated with the endothelium
at the base of the cluster, whereas actively cycling (S/G2/M)
pre-HSCs type I emergemore apically (Figure 5B). By E11.5,
the base of clusters still consists of slowly cycling cells, butStem Cell Reports j Vol. 8 j 1–14 j June 6, 2017 9
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actively cycling pre-HSC type II develop in more apical po-
sitions. This organization was observed in at least 50% of
intra-aortic clusters in E10.5 and E11.5 embryos. Similarly
structured, although often significantly larger, hematopoi-
etic cell clusters were also observed in extra-embryonic ar-
teries. This suggests that clusters are initiated by slowly
cycling precursors, which give rise to more mature actively
proliferating precursors moving toward apical positions.
This organization of clusters is maintained throughout
their maturation, suggesting their growth through pre-
dominant expansion of more mature pre-HSCs. This matu-
ration of clusters correlates with progressive quantitative
expansion of the pre-HSC population identified function-
ally by transplantations (Rybtsov et al., 2016).
c-KIT/SCF signaling is essential for HSC biology (Ikuta
and Weissman, 1992; Thore´n et al., 2008; Ding et al.,
2012; Marcelo et al., 2013). We have shown that SCF is
ventrally polarized in the AGM region and is a key regulator
of stepwise pro-/pre-HSC transitions (Souilhol et al., 2016).
c-KIT is expressed in pro-/pre- and dHSCs, and is a principal
marker for HSCs in the adult animal (Rybtsov et al., 2014;
Kiel et al., 2005). Since c-KIT/SCF signaling is implicated
in the regulation of proliferation (Sasaki et al., 2010; Ema
et al., 2000; Bashamboo et al., 2006), we studied the organi-
zation of c-KIT expressing cells in developing intra-aortic
clusters and found that slowly cycling cells, including
those at the base of the cluster, express low levels of
c-KIT, whereas actively cycling cells express high levels of
c-KIT. Although further experimentation is needed to
understand this observation mechanistically, this suggests
that the stratified proliferative architecture of the cluster is
at least partly defined by c-KIT/SCF signaling. Our analysis
provides a basis for investigation of cellular and molecular
events in maturing intra-aortic clusters in connection with
pro/pre-HSC expansion in the AGM region.
Cell proliferation plays an important role in various dif-
ferentiation processes and needs to be tightly regulated.
For example, lengthening G1 phase increases differentia-
tion of neural stem cells into neurons (Lange and Calegari,
2010; Lange et al., 2009); cyclin D in human embryonic
stem cells controls balance between neuroectoderm and
endoderm specification (Pauklin and Vallier, 2013); and
deletion of p27 cell-cycle inhibitor prevents specification
of hematopoietic cells from the yolk sac endothelium
(Marcelo et al., 2013). The temporal kinetics of pre-HSC
proliferation is well controlled: although mature fetal
liver HSCs expand, their proliferative activity decreases
compared with the AGM region and subsequently, in the
adult bone marrow, switches into quiescence associated
with low c-KIT expression, which is necessary to prevent
exhaustion of the HSC pool (Thore´n et al., 2008; Matsuoka
et al., 2011; Shin et al., 2014). Our data indicate that pre-10 Stem Cell Reports j Vol. 8 j 1–14 j June 6, 2017HSC expansion within the AGM region is driven by prolif-
eration. It needs to be elucidated in future whether stage-
specific proliferative changes per se play a role in HSC
maturation.
In summary, our analysis defines changes in proliferative
status of the developing HSC lineage at pre-liver stages. We
found that dramatic expansion of maturing HSCs corre-
lates with their active proliferation, likely driven by c-
KIT/SCF signaling. Proliferative analysis revealed previ-
ously concealed heterogeneity within the pre-HSC popula-
tions. We describe the proliferative organization of intra-
aortic clusters that correlates with the functionally defined
status of HSC precursors. This study lays a foundation for
molecular analysis of mechanisms underlying HSC devel-
opment within intra-aortic hematopoietic clusters.EXPERIMENTAL PROCEDURES
Mice
Mice were housed and bred in animal facilities at the University of
Edinburgh in compliance with UK Home Office Regulations. Em-
bryos for experiments were obtained from intercrossing heterozy-
gous hCdt1(30/120)-mKO2 (#610) and hGeminin(1/110)-mAG
(#474) mice (Sakaue-Sawano et al., 2008; Yo et al., 2015; Zielke
and Edgar, 2015) or from C57BL/6 CD45.2/2 mice. The day of dis-
covery of the vaginal plug was designated as day 0.5. The embryos
were additionally staged based on somite pair (sp) numbers (E9.5 =
26–29 sp, E10.5 = 30–38 sp, E11.5 = 41–45 sp). C57BL/6 CD45.1/2
micewere used as transplant recipients andC57BL/6CD45.1/1 as a
source of carrier cells. All experiments with animals were approved
under a Project License granted by the Home Office (UK) and the
University of Edinburgh Ethical Review Committee, and conduct-
ed in accordance with local guidelines.Flow Cytometry and Cell Sorting
Single-cell suspensions from the AGM region or fetal liver
were prepared by dispase/collagenase-mediated dissociation, while
single-cell suspensions from bone marrow were obtained by
flushing the tibias and femurs with a 26-gauge syringe needle (BD
Microlance). Antibodies used for staining of cells were: anti-CD45-
BV450 or BV650 (BD Horizon, clone 30F11), anti-VE-cadherin-
A647 (BioLegend, Clone eBioBV13), biotinylated anti-VE-cadherin
(clone 11.D4.1) followed by incubation with streptavidin-
APC (BD Pharmingen), anti-CD43-PE or biotinylated anti-CD43
(eBioscience, clone eBioR2/60) followed by incubationwith strepta-
vidin-BV650 (BioLegend), anti-CD41-PE or BV421 (BioLegend,
clone MWReg30), anti-Sca1-BV421 or PE-Cy7 (eBioscience,
clone D7), anti-c-KIT/CD117-BV421 (BioLegend, clone 2B8),
anti-CD150-APC (BioLegend, clone TC15-12F12.2), anti-CD48-
PerCPefluor710 (BioLegend, clone HM48-1), anti-Ki67-AF647 (BD
Pharmingen, clone B56), DAPI (Biotium), anti-Ter119-PerCp-
Cy5.5 or biotinylated anti-Ter119 (eBioscience), biotinylated anti-
B220/CD45R (eBioscience, clone RA3-6B2), biotinylated anti-
CD3e (eBioscience, clone 145-2C11), and biotinylated anti-Gr1
(eBioscience, clone RB6-8C5). Lineage depletion of bone marrow
Please cite this article in press as: Batsivari et al., Understanding Hematopoietic Stem Cell Development through Functional Correlation of
Their Proliferative Status with the..., Stem Cell Reports (2017), http://dx.doi.org/10.1016/j.stemcr.2017.04.003and fetal liver samples was performed by streptavidin particles (BD
IMag)according to themanufacturer’s instructions.7-Aminoactino-
mycin D viability staining solution, live-dead dye Zombie Aqua
(BioLegend), or Infra-Red (Invitrogen) were used to exclude dead
cells and gates were set using appropriate fluorescence minus one
(FMO) controls. Flow-cytometry analysis was performed on a For-
tessa LSR using FACSDiva software, while analysis was done using
FlowJo 10. Sorting was performed on a FACSAriaII using FACSDiva
software. Correlation analysis between c-KIT levels and cell-cycle
phases was performed using GraphPad Prism. The different cell-
cycle fractions were plotted against c-KIT in FlowJo and segmented
in equal parts across the c-KIT axis. The cell numbers within
each segment/gate were extracted from FlowJo and used for the
correlation analysis. A correlation coefficient (r) of +1 indicates
perfect positive correlation (i.e., when x increases then y increases),
whereas 1 shows negative/inverse correlation (i.e., when x in-
creases then y decreases). A correlation coefficient of 0 shows that
the two variables do not vary at all. R2, or coefficient of determina-
tion, is the fractionof thevariance in the twovariables that is shared.
The p values in this analysis showwhether the correlation is due to
random sampling. Nonlinear regression analysis was used to draw a
graph with a smooth curve that fits the data.OP9 Co-aggregates
E9.5 caudal parts or E10.5–E11.5 AGM regions were isolated
and for some experiments were subdissected into AoV, AoD, and
UGRs. Thenotochordwas included in the AoD. Sorted populations
were co-aggregated with OP9 stromal cells as previously described
(Rybtsov et al., 2011, 2014). In all experiments, 1 embryo equiva-
lent (ee), defined as a unit of cells equivalent to the number present
in one organ (e.g., 0.2ee corresponds to 20% of cells present in one
AGM region), of sorted cells was co-aggregated with 100,000 OP9
cells. Cell aggregates were cultured at the liquid-gas interface on
0.8 mm of mixed cellulose MF-membranes (AAWP02500, Milli-
pore) for 5–7 days (37C, 5% CO2) in 5 mL of Iscove’s modified
Dulbecco’s medium (IMDM, Invitrogen), 20% fetal calf serum
(FCS; HyClone, ThermoScientific) supplemented with L-gluta-
mine (4 mM), penicillin/streptomycin (50 units/mL) and
100 ng/mL SCF, 100 ng/ml IL-3, and 100 ng/mL Flt3l (all pur-
chased from Peprotech). Suitable batches of FCS supporting
effective maturation of pre-HSCs were selected after pre-testing
in preliminary transplantation experiments (Taoudi et al., 2008).
Cells from E9.5–E10.5 AGM regions were cultured for 7 days, while
cells from E11.5 AGM regions were cultured for 5 days.HSC Transplantation and CFU-C Assay
AGM tissues from C57BL/6 CD45.2/2 embryos were pooled and
cell suspensions obtained after dissociation with collagenase/dis-
pase (Roche) for 40 min at 37C. Dissociated cells were plated in
methylcellulose culture that contains cytokines (MethoCult3434
medium; STEMCELL Technologies) according to the manufac-
turer’s instructions. Donor cells were injected intravenously into
C57BL/6 CD45.1/2 sublethally irradiated (1,150 rad) mice along
with 50,000 C57BL/6 CD45.1/1 bone marrow carrier cells. The
amount of transplanted cells is expressed in ee and the dose
injected for each experiment was chosen based on the expectedoutcome of dHSC numbers, which can vary depending on the
developmental stage.
Long-term hematopoietic repopulation by donor cells was as-
sessed in peripheral blood between 14 and 16 weeks after trans-
plantation. Peripheral blood was collected by bleeding the tail
vein into 500 mL of 5 mM EDTA/PBS. Erythrocytes were depleted
using PharM Lyse (BD Biosciences). Cells were stained with anti-
CD16/32 (Fc-block), anti-CD45.1-V450 (cloneA20), and anti-
CD45.2-APC (clone 104) monoclonal antibodies (eBioscience)
and analyzed using a FACSCalibur. Data were analyzed in FlowJo
software (TreeStar). Mice exhibiting >5% of donor chimerism
were considered to be repopulated with dHSCs. Different groups
of repopulated mice were compared using one-way ANOVA or
t test (*p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.0001). Limiting
dilution analysis of fetal liver was performed using ELDA software
(Hu and Smyth, 2009).Immunofluorescence
Whole-mount immunostaining was performed as previously
described (Yokomizo et al., 2012) with slight modifications.
Embryos dissected from the yolk sac and amnion were fixed with
2% paraformaldehyde or cold acetone and, following dehydration
by increasing concentrations of methanol, the head, limbs, and
one body wall were removed. After rehydration in 50%methanol,
washingwithPBS, andblocking in50%FCS/0.5%TritonX-100, the
samples were incubated overnight with antibodies. For staining
with antibodies from the same species, incubations were per-
formed sequentially. Primary antibodies used were unconjugated
goat anti-mouse CD43 (Santa Cruz Biotechnology, clone M19),
rat anti-mouse VE-cadherin (BD Pharmingen, clone 11D4.1),
rat anti-mouse CD45 (BD Pharmingen, clone 30-F11), rabbit
anti-mouse RUNX1 (Abcam, clone EPR3099), rat anti-mouse
CD41 (BD Pharmingen, clone MWReg30), rat anti-mouse c-KIT
(BioLegend, clone 2B8), rabbit anti-mouse Ki67 (Abcam, clone
SP6), rabbit anti-mAG (MBL International), and rabbit anti-
mKO2 (MBL International), and thesewere detectedby the second-
ary antibodies anti-goatNL557 (R&D Systems), anti-rat Alexa Fluor
647 (Invitrogen), or anti-rat Alexa 488 (Invitrogen) and anti-rabbit
Alexa Fluor 647 (Abcam). After washing, the embryos were dehy-
drated with methanol and cleared with BABB (one part benzyl
alcohol, two parts benzyl benzoate) solution (Yokomizo and Dzier-
zak, 2010). Secondary antibody only controls were used in all the
experiments. Imaging of live sections was performed as previously
described (Boisset et al., 2011) with slight modifications. E10.5
mouse embryos were dissected and cut into slices of 300-mm thick-
ness using a tissue chopper. Slices were stained against c-KIT-APC
(eBioscience, clone 2B8) for 10min at 4C, thenplaced in glass-bot-
tom dishes (MatTek) and covered with low-melting-point agarose
gel (4%). The gel was then covered with IMDM without phenol
red. Images were acquired with an inverted confocal microscope
(Leica SP8) and processed using Volocity software.SUPPLEMENTAL INFORMATION
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